These drugs “consistently show VHD in about 25 percent of those exposed, which is an outrageously high incidence rate for a potentially irreversible valvular heart disease that may require surgery or cause death compared to other drugs with long-term adverse effects,” said Thomas, who also is an associate professor in pharmacy at Touro University California.